New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers
Abstract Cisplatin is the first and most widely used platinum-based chemotherapy drug and is the cornerstone agent in treating a broad spectrum of cancers. However, its clinical application is often limited by severe toxic side effects and drug resistance. Based on the discovered dissociative electr...
Guardado en:
Autores principales: | Qinrong Zhang, Qing-Bin Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b840da4cafb4edda19ef2f7542f0ab8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cisplatin is retained in the cochlea indefinitely following chemotherapy
por: Andrew M. Breglio, et al.
Publicado: (2017) -
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Raoud Marayati, et al.
Publicado: (2021) -
Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels
por: Zhao X, et al.
Publicado: (2018) -
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
por: Qi Zhong, et al.
Publicado: (2018) -
Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo
por: Marina V. Shirmanova, et al.
Publicado: (2017)